Sign in

Nea Management Company, LLC

CIK:0001512848
Venture Capital
$28B AUM
32 holdings
Timonium, MD, United States
Founded:1977
112 employees
Latest filing:Jun 30, 2025

NEA Management Company, LLC is the registered investment adviser affiliate of New Enterprise Associates (NEA), headquartered in Timonium, Maryland, USA. Founded in 1977, NEA is one of the world’s largest venture capital firms, employing over 110 people. The firm primarily serves institutional investors, entrepreneurs, and high-growth technology and healthcare companies, focusing on early, growth, and late-stage investments globally.

Investment Strategy

NEA Management Company, LLC focuses on venture capital investments across technology and healthcare sectors, engaging in funding early-stage startups as well as growth and late-stage businesses. The firm’s approach emphasizes long-term partnerships with entrepreneurs, providing capital, operational expertise, and a broad network to facilitate growth and innovation. NEA’s investment philosophy centers on diversification and value-add support, targeting transformative opportunities with scalability and disruptive potential.

Top Buys
V
VRNAVERONA PHARMA PLC
+$43.4M
R
RYTMRHYTHM PHARMACEUTICALS INC
+$29.7M
O
ORICORIC PHARMACEUTICALS INC
+$29.6M
C
COURCOURSERA INC
+$27.0M
C
CRSPCRISPR THERAPEUTICS AG
+$23.2M
Top Sells
T
TEMTEMPUS AI INC
-$126.2M
C
CVRXCVRX INC
-$12.9M
S
SVRASAVARA INC
-$12.0M
R
RGLSREGULUS THERAPEUTICS INC
-$11.3M
D
DMDESKTOP METAL INC
-$7.1M

Top Holdings

A
ACLXARCELLX INC
+18.6%$246.6M
V
VRNAVERONA PHARMA PLC
+16.1%$214.0M
R
RYTMRHYTHM PHARMACEUTICALS INC
+13.8%$183.9M
C
COURCOURSERA INC
+8.5%$112.7M
C
CRSPCRISPR THERAPEUTICS AG
+5.8%$77.2M

Equity Positions (31)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
A
ACLX
ARCELLX INC18.56%$246.6M3,745,262$14.21$65.85+$936.3K
V
VRNA
VERONA PHARMA PLC16.11%$214.0M2,263,138$8.76$94.58+$43.4M
R
RYTM
RHYTHM PHARMACEUTICALS INC13.84%$183.9M2,909,956$29.06$63.19+$29.7M
C
COUR
COURSERA INC8.49%$112.7M12,867,769$45.00$8.76+$27.0M
C
CRSP
CRISPR THERAPEUTICS AG5.81%$77.2M1,587,854$22.19$48.64+$23.2M

Industry Allocation

PHARMACEUTICAL PREPARATIONS
+56.6%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+29.2%
SERVICES-PREPACKAGED SOFTWARE
+8.5%
SERVICES-MEDICAL LABORATORIES
+2.3%
HOSPITAL & MEDICAL SERVICE PLANS
+1.4%